4.6 Review

Role of Myeloid-derived suppressor cell (MDSC) in autoimmunity and its potential as a therapeutic target

Journal

INFLAMMOPHARMACOLOGY
Volume 29, Issue 5, Pages 1307-1315

Publisher

SPRINGER BASEL AG
DOI: 10.1007/s10787-021-00846-3

Keywords

MDSC; Autoimmunity; Rheumatoid arthritis; Diabetes; multiple sclerosis

Ask authors/readers for more resources

Myeloid suppressor cells play a crucial role in autoimmune diseases by regulating T cell function, making them a potential target for therapy. Despite significant progress in understanding their involvement in autoimmune diseases, many questions surrounding MDSC activation and functions remain unanswered.
Myeloid suppressor cells (MDSCs) are an important class of immune-regulating cells that can suppress T cell function. Most of our knowledge about the function of MDSC comes from studies of cancer models. Recent studies, however, have greatly contributed to the description of MDSC involvement in autoimmune diseases. They are known as a cell population that may negatively affect immune responses by regulating the function of CD4(+) and CD8(+) cells, which makes them an attractive target for autoimmune diseases therapy. However, many questions about MDSC activation, differentiation, and inhibitory functions remain unanswered. In this study, we have summarized the role of MDSCs in various autoimmune diseases, and the potential of targeting them for therapeutic benefits has been discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available